Bleeding Through | |
Type: | studio |
Artist: | Bleeding Through |
Cover: | BleedingThrough - SelfTitled.jpg |
Recorded: | December 2009 – January 2010 |
Studio: | Planet Z Studios in Hadley, Massachusetts |
Genre: | Metalcore, melodic death metal, symphonic black metal |
Length: | 45:34 |
Label: | Rise (US), Distort (Canada), Roadrunner (UK) |
Producer: | Zeuss |
Prev Title: | Declaration |
Prev Year: | 2008 |
Next Title: | The Great Fire |
Next Year: | 2012 |
Bleeding Through is the sixth studio album by American metalcore band Bleeding Through. The album was released through Rise Records on April 13, 2010.[1]
The eponymous album is the band's first release through Rise Records after a very open and public fallout with their previous label, Trustkill Records, in 2008.[2] Bleeding Through announced the split with Trustkill shortly after releasing their previous album, Declaration. In late 2009, the band announced their signing to Rise Records. Craig Ericson, President of Rise expressed his excitement to work with Bleeding Through stating, "We've been huge fans ever since they released an album on Indecision Records. Having Bleeding Through in the family is a dream come true. We both share extreme passion for music and can't wait to show the world what we can achieve together as a team."[3] The band was mutually excited to work with Rise, due to the label's enthusiasm to help the band grow and reach their potential. Vocalist Brandan Schieppati stated, "After 10 years, we have been content with the fan base, the familiarity of touring and the comfort of knowing what to expect at every show. Rise wants to build on that."[4]
Bleeding Through is also the first studio album to feature Dave Nassie, who has previously played in punk rock groups No Use for a Name, 22 Jacks, Suicidal Tendencies and the funk metal band Infectious Grooves.[5] Nassie replaced former guitarist Jona Weinhofen, who left Bleeding Through after two years due to Trustkill not paying royalties and returned home to Australia.[5] [6]
Bleeding Through debuted at number 143 on the US Billboard 200 with 3,700 copies sold in the first week. This is significantly lower than the band's previous album, 2008's Declaration, which peaked at number 101 and sold 6,000 copies in the first week.[7]
Bleeding Through
Production